Mayo Clinic Researchers Identify Immune Cell Inhibitor Strategy for Glioblastoma Treatment
Source Summary
Mayo Clinic researchers have identified a potential new treatment approach for glioblastoma that uses an inhibitor to convert tumor-protecting immune cells into cancer-fighting agents. The approach could enhance the effectiveness of existing chemotherapy treatments for this aggressive brain cancer.
Why it matters
This research offers a potential new therapeutic strategy for glioblastoma, an aggressive brain cancer with limited treatment options, by redirecting the immune system's response.
